NCT02712203View on ClinicalTrials.gov

MMR and MMRV Vaccines: Effect of Age at First Dose on Safety and Immunogenicity of the Measles Component.

UnknownOBSERVATIONAL

Enrollment

5,808

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

July 31, 2010

Study Completion Date

December 31, 2016

Conditions

Measles

Interventions

BIOLOGICAL

MMR vaccine / MMRV vaccine

Subcutaneous injection, two doses

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

CHU de Quebec-Universite Laval

OTHER

NCT02712203 - MMR and MMRV Vaccines: Effect of Age at First Dose on Safety and Immunogenicity of the Measles Component. | Biotech Hunter | Biotech Hunter